Option chain shows key data for Magic Empire Glb's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Magic Empire Glb.

Magic Empire Glb (NASDAQ:MEGL) Stock, Option Chain

Magic Empire Global

Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.

News

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

Movers

Trading Ideas

ATRA

BCEL

BETS

BIOR

CAMP

CANO

CCTG

CHEA

CVKD

DCFC

FDMT

GRDI

MEGL

NEXI

NSTG

TWOU

WORX

Shares of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) rose sharply in today’s pre-market trading.

4DMT presented interim data from randomized Phase 2 PRISM clinical trial of intravitreal 4D-150 demonstrating favorable tolerability &amp; clinical activity in wet AMD.

Why 4D Molecular Therapeutics Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket

Intraday Update

ANIP

BAOS

BLCM

BTBT

BTOG

CLSK

CRKN

CTLT

EZFL

FRBK

FUBO

GDOT

GLMD

GTEC

HLTH

IDEX

IMPP

IMRN

INOD

IONM

LYEL

MARA

MDJH

MINM

NBTX

NSSC

OKYO

OPEN

RIOT

SVFD

TNYA

TRUP

TRVN

USGO

VCIG

ZAPP

Gainers


	Trevena, Inc. (NASDAQ: TRVN) shares surged 170% to $1.74 after the company announced the approval of OLINVYK in China.


Why Tredegar Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

HCDI

HSCS

SVRE

Gainers


	Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) gained 105.2% to $0.8001 in pre-market trading. Bellicum Pharmaceuticals 13D filing showed Baker Bros. Advisors reported a 19.99% active stake in the company.


Why Bellicum Pharmaceuticals Shares Are Trading Higher By 105%; Here Are 20 Stocks Moving Premarket

Magic Empire Global Limited - Ordinary Shares

Magic Empire Global Ltd

Meta Platforms Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) Instagram has the potential to generate 50% of the company&#8217;s advertising revenue in the U.S., Bloomberg <a target="_blank" href="https://www.bloomberg.com/news/articles/2024-12-18/instagram-expected-to-generate-50-of-meta-s-us-ad-sales-in-2025?sref=TBDibEcD" rel="noreferrer noopener">cites</a> from Emarketer estimates.
Instagram could breach $32 billion in U.S. advertising revenue in 2025, up over 24% in 2024, as its short-form video product Reels gain traction, Bloomberg cites Emarketer. The video-sharing app boasts over 148 million American users.
Also Read: <a target="_blank" href="https://www.benzinga.com/media/24/12/42554393/disneys-marvel-rivals-game-hits-20-million-players-proves-superhero-power-still-reigns" rel="noreferrer noopener">Disney&#8217;s Marvel Rivals Game Hits 20 Million Players, Proves Superhero Power Still Reigns</a>
By early 2022, Instagram accounted for nearly 30%&nbsp;of Meta&#8217;s global business from 27% in 2021, Bloomberg cited court filings.
Reels competes with ByteDance&#8217;s TikTok and Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) YouTube Shorts.
Meta&#8217;s focus on video content has been instrumental to its growth, as users devoted nearly 67% of their Instagram time to surfing videos, Bloomberg cited Jasmine Enberg of Emarketer.
<a target="_blank" href="https://www.benzinga.com/24/12/42369266/meta-reddit-stocks-climb-record-highs-as-tiktoks-battle-against-us-ban-continues-after-court-ruling" rel="noreferrer noopener">The TikTok ban</a> could serve as a tailwind for Instagram, helping it win over 20% of reallocated TikTok ad dollars in the U.S, Reuters cites Enberg.
Meta previously told Instagram Reels accounted for over 50%&nbsp;of the time people spend on the app.
In 2024, 53.7% of Instagram&#8217;s ad revenue primarily came from its Feed features and 24.6% from Stories features. With Reels&#8217; revenue boost, the combined revenue share from Instagram Explore, Reels, and Threads could rise 9.6% in 2025.
In October, BofA Securities analyst Justin Post <a target="_blank" href="https://www.benzinga.com/news/24/10/41465662/metas-reels-monetization-and-ai-innovations-drive-top-ai-pick-analyst" rel="noreferrer noopener">projected Meta&#8217;s upside</a> from ramping up Messaging and Reel monetization powered by new artificial intelligence tools and CRM integration.
Meta Platforms stock surged 79% year-to-date. Investors can gain exposure to the stock through Vanguard Communication Services ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOX#NYSE">VOX</a>) and The Communication Services Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>).
<h2 class="wp-block-heading">Is Meta A Good Stock To Buy?</h2>
An investor or trader's decision to buy or sell a stock is unique to their time horizon and risk tolerance. Many typical investors evaluate earnings growth and valuation on a particular stock before making a decision. 
For example, for Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), you'll notice that earnings in its last quarter grew 14.86% <a href="https://www.benzinga.com/quote/META/earnings">source</a>. As an investor, you'll want to decide whether that's better or worse than what you'd like to see among stocks in your portfolio. 
On the valuation side, Meta Platforms's price to earnings ratio &#8211; a measure of how much an investor pays for the company's earnings &#8211; is compressed 15.56% in the current quarter when compared with last year. That places it below similar businesses Alphabet, Baidu, Pinterest in its sector. You'll need to decide whether that makes it more or less attractive based on how you think the company will perform over time.
There are many different valuation metrics that may help you make a decision. Find more on <a href="https://www.benzinga.com/quote/META">Meta Platforms's quote page</a>, or if you'd like a deeper dive in an advanced program, try <a href="https://pro.benzinga.com">Benzinga PRO</a> for free.
Price Action: META stock is up 1.15% at $626.545 at the last check on Wednesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/24/12/42553094/jabil-q1-earnings-tops-expectations-cloud-and-data-center-growth-outlook" target="_blank" rel="noreferrer noopener">Jabil Q1 Earnings: Revenue And EPS Beat, Cloud and Data Center Growth, Raises Annual Outlook</a></li>
</ul>
Photo via Shutterstock

Tech

Media

GOOG

GOOGL

Instagram's Ad Revenue Could Hit $32 Billion by 2025, Driving Meta's Growth: Report

WIIM

AZTA

Azenta shares are trading higher after Stephens & Co. upgraded the stock to Overweight from Equal-Weight and raised its price target from $50 to $60.

Eos Energy Enterprises, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EOSE#NASDAQ">EOSE</a>) stock is trading higher on Wednesday after the company announced it secured a 400 MWh <a href="https://www.benzinga.com//node/42552632">standalone storage order</a> with International Electric Power.
The Details: This order is part of a project to be deployed at Marine Corps Base Camp Pendleton in San Diego, California which aims to enhance grid resiliency for the U.S. Navy and Marine Corps.
The project, supported by funding from the California Energy Commission's Long Duration Energy Storage Program, will use Eos Z3 batteries and is scheduled for delivery beginning in 2025. The Eos Z3 Cubes are safe, non-flammable and don't require cooling systems, which helps minimize noise and reduce operational costs.
&#8220;IEP and CEC are at the forefront of North American long-duration energy storage, and their partnership has been invaluable as Eos transitions into a profitable operating company. They recognize the need for multiple storage technologies and the energy security that an American-made product provides,&#8221; added Joe Mastrangelo, Eos CEO.
&#8220;It&#8217;s an honor to have been selected for such an important installation at Camp Pendleton.&#8221;
Related Link: <a href="https://www.benzinga.com/insights/options/24/12/42557838/palantir-technologies-unusual-options-activity">Palantir Technologies Unusual Options Activity</a>
EOSE Price Action: At the time of writing Eos Energy stock is trading 14.7% higher at $4.48, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: Shutterstock

EOSE

What's Going On With Eos Energy Stock Wednesday?

Theratechnologies Inc. ("Theratechnologies" or the "Company") (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TH#TSX">TH</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THTX#NASDAQ">THTX</a>), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that the Company has submitted a Prior Approval Supplement (PAS) to the U.S. Food and Drug Administration (FDA) describing the changes made to the manufacturing environment of the facility where EGRIFTA SV&#xAE; is produced. A PAS is reviewed by the FDA within four months of receipt and an approval is needed prior to the distribution of the <a href="https://www.globenewswire.com/Tracker?data=8zHQ9qiyFO30h9BOfieWluYkNSdMsyvq24uHfuCufIVJuAcz2MC2Wi8JwO3uxPJK5Zg4Hnxe9yRK0YL8b-VwzIBT6sI1dIqefPxyrQH9SQcGs96Be7BtzwxdO12cw4ciN0DBUaDXb2Ey9HpTsYJ1aBwYpdHX5l1dgbBweAE30nUjyjJdJMuySCqOg_9-Q9R4FdrlVrl3X8KTmjgYmunrjBVx1NwAWJWd66efKQ6DFRo=">recently manufactured</a> batches of&nbsp;EGRIFTA SV&#xAE;.
Existing inventory levels of&nbsp;EGRIFTA SV&#xAE; are expected to meet patient demand until mid-January 2025. Theratechnologies therefore continues discussions with the relevant FDA divisions in an effort to accelerate the release of EGRIFTA SV&#xAE; and avoid a product shortage at the patient level.
The Company will update the market on any further material developments.
EGRIFTA SV&#xAE; is distributed in the United States only.

Biotech

General

THTX

TSX:TH

Theratechnologies Has Submitted A Prior Approval Supplement To The U.S. FDA Describing The Changes Made To The Manufacturing Environment Of The Facility Where EGRIFTA SV Is Produced

QBTS

D-Wave Quantum shares are trading higher amid continued volatility in quantum stocks.

<a href="https://economictimes.indiatimes.com/tech/funding/bureau-secures-30-million-from-sorenson-capital-paypal-ventures-existing-investors/articleshow/116406362.cms?from=mdr" title="https://economictimes.indiatimes.com/tech/funding/bureau-secures-30-million-from-sorenson-capital-paypal-ventures-existing-investors/articleshow/116406362.cms?from=mdr">https://economictimes.indiatimes.com/tech/funding/bureau-secures-30-million-from-sorenson-capital-paypal-ventures-existing-investors/articleshow/116406362.cms?from=mdr</a>

Contracts

PYPL

Reported Earlier, 'Bureau Secures $30M From Sorenson Capital, PayPal Ventures, Existing Investors' - Economic Times

In the current session, the stock is trading at $93.06, after a 0.44% spike. Over the past month, Lantheus Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNTH#NASDAQ">LNTH</a>) stock increased by 7.65%, and in the past year, by 56.81%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2024/1734546613_0.png" alt="Past Year Chart" />

<h3>Lantheus Holdings P/E Ratio Analysis in Relation to Industry Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Lantheus Holdings has a lower P/E than the aggregate P/E of 48.6 of the Health Care Equipment &amp; Supplies industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1734546613_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

LNTH

P/E Ratio Insights for Lantheus Holdings

NUKK

Nukkleus Shares Halted On Circuit Breaker To The Upside, Stock Now Up 377%

Nukkleus Inc Shares Resume Trading

EGHT

8x8 shares are trading higher after Morgan Stanley raised its price target on the stock from $2 to $2.6.

Micron Technology Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) heads into its <a href="https://www.benzinga.com/quote/MU/earnings">first-quarter earnings</a> announcement with a mix of optimism and caution.
<h1 class="wp-block-heading">"Choppy Quarters Ahead"?</h1>
As Jake Silverman, Bloomberg Intelligence Semiconductor Analyst, puts it, "choppy quarters ahead for NAND" could pose a challenge, with pricing and inventory pressures in the smartphone and PC markets.
However, the analyst also highlights AI-related applications as a potential offset, giving Micron a chance to weather the storm.
Read Also: <a href="https://www.benzinga.com/24/12/42553082/how-to-earn-500-a-month-from-micron-stock-ahead-of-q1-earnings">How To Earn $500 A Month From Micron Stock Ahead Of Q1 Earnings</a>
<h1 class="wp-block-heading">Bullish Technical Signals Keep Optimists In The Game</h1>
Micron's stock, currently trading at $110.93, flashes bullish signs across key technical indicators. 
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="630" height="493" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18114211/Screenshot-2024-12-18-at-10.11.43-PM.png" alt="" class="wp-image-698134" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18114211/Screenshot-2024-12-18-at-10.11.43-PM.png 630w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18114211/Screenshot-2024-12-18-at-10.11.43-PM-300x235.png 300w" sizes="(max-width: 630px) 100vw, 630px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121824&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
It sits well above short- and medium-term moving averages, with the eight-day simple moving average (SMA) at $103.94, the 20-day SMA at $102.07 and the 50-day SMA at $104.07. 
The Moving Average Convergence Divergence (MACD) at 1.15 also suggests momentum is on the bulls' side.
However, the 200-day SMA of $110.93 coincides with the price, remaining a hurdle, signaling a potential resistance level.
<h1 class="wp-block-heading">AI: A Light At The End Of The NAND Tunnel?</h1>
The market will be laser-focused on how Micron balances the dynamics of two divergent forces:
<ol>
<li>NAND Weakness: Elevated inventories and pricing pressure.</li>
<li>AI Opportunities: As Silverman notes, secular growth in AI applications could provide a much-needed boost, potentially offsetting the broader NAND market challenges.</li>
</ol>
<h1 class="wp-block-heading">What's Expected?</h1>
Analysts estimate an EPS of $1.76 and revenue of $8.72 billion. But beyond these numbers, investors will be scrutinizing the company's guidance. Can Micron sustain its AI-driven growth momentum, or will "choppy quarters" in NAND drag it down?
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/previews/24/12/42549182/us-stocks-to-open-higher-as-rate-cut-expectations-surge-all-eyes-on-dow-jones-to-break-its-9-day-losing-streak">US Stocks To Open Higher As Rate Cut Expectations Surge: All Eyes On Dow Jones To Break Its 9-Day Losing Streak</a></li>
</ul>
Photo: NPS_87 on Shutterstock

Technicals

Previews

Micron Earnings: Will AI Growth Outweigh 'Choppy' Memory Market?

Nukkleus Shares Halted On Circuit Breaker To The Upside, Stock Now Up 319.6%

With Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) prices peaking to all-time high levels, MicroStrategy's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) aggressive Bitcoin accumulation strategy has once again become a focal point in discussions among <a href="https://www.benzinga.com/markets/equities/24/12/42503221/microstrategy-shares-surge-nearly-7-amid-nasdaq-100-inclusion-and-bitcoins-new-record-high">traders and analysts</a>.
What Happened: In a tweet on Monday, industry expert Alex Kolicich addressed common misconceptions about MSTR in a recent tweet, explaining that the stock is neither a leveraged nor a synthetic call option on Bitcoin. 
Instead, Kolicich pointed out several structural inefficiencies:
<ul>
<li>MSTR trades at a 140% premium to its Bitcoin holdings&#8217; net asset value (NAV).</li>
<li>Each $1 invested in MSTR stock provides only $0.45 of Bitcoin exposure, far less than direct Bitcoin ownership.</li>
</ul>
Kolicich further <a href="https://x.com/AlexKolicich/status/1868705490387321177">elaborated</a> that MicroStrategy is not leveraged but instead deleveraged, offering reduced Bitcoin exposure compared to direct investments. 
He highlighted alternatives like BITX, which provide 2x leverage without a NAV premium.
Additionally, while traditional call options on assets typically offer leveraged upside due to their long volatility exposure, MSTR's convertible bonds effectively short volatility, diluting shareholder returns as Bitcoin prices rise.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42509614/microstrategy-expands-bitcoin-holdings-by-15350-btc-worth-15-billion-after-joining-nasdaq-100">MicroStrategy Expands Bitcoin Holdings By 15,350 BTC Worth $1.5 Billion After Joining Nasdaq 100</a>
Why It Matters: Crypto trader TheFlowHorse on Dec. 17 in a post on X emphasized the implications of Saylor&#8217;s aggressive Bitcoin purchases, noting that these acquisitions have significantly raised MicroStrategy's DCA to $61,000. 
This figure is approximately 40% higher than Bitcoin's current price, introducing potential risks if prices fail to recover significantly.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Take a look at Saylor&#39;s recent Bitcoin buys. The buys up here are so large that he has increased his dollar cost average price by nearly 50%, to 61k. That level is around 40% away. We haven&#39;t had a pullback of that magnitude for years, but at some point you have to wonder if in… <a href="https://t.co/erhdvrErn2">pic.twitter.com/erhdvrErn2</a>
&mdash; HORSE (@TheFlowHorse) <a href="https://twitter.com/TheFlowHorse/status/1868763016642052542?ref_src=twsrc%5Etfw">December 16, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Analysts warn that while Bitcoin&#8217;s pullbacks have historically been rare, Saylor's strategy could leave MSTR exposed to potential downside risk, especially with its C-Corp structure subject to double taxation, unlike <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42275232/leveraged-microstrategy-etfs-are-playing-with-fire-experts-warn">more efficient ETFs</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42522606/trump-is-serious-about-creating-a-bitcoin-reserve-says-microstrategys-michael-saylorurges-to-buy-btc-before-it-goes-up-by-100x">Trump Serious About Bitcoin Reserve, Says MicroStrategy&#8217;s Michael Saylor: &#8216;Buy It Now And Own The Future&#8217;</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

MSTR

MicroStrategy's Aggressive Bitcoin Strategy Raises Eyebrows In Crypto Community

Corvus Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRVS#NASDAQ">CRVS</a>) released interim data from a Phase 1 trial evaluating soquelitinib in patients with moderate to <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/g42550503/corvus-pharmaceuticals-announces-interim-data-from-placebo-controlled-phase-1-clinical-trial-of-so" rel="noreferrer noopener">severe atopic dermatitis</a>.&nbsp;
The trial will enroll 64 patients with moderate to severe atopic dermatitis who previously failed one prior topical or systemic therapy.
These doses were selected based on the company&#8217;s prior experience evaluating soquelitinib in T-cell lymphoma patients.
The company is reporting complete results from Cohort 1 of the trial, which includes 16 patients (12 who received soquelitinib 100 mg oral twice per day and four who received placebo), with follow-up at 28 days and 58 days.
The mean baseline EASI and IGA scores for soquelitinib patients were 20.4 and 3.0, respectively, compared to 18.5 and 3.3 for placebo patients.
EASI scores at 28-day and 58-day follow-up demonstrate a favorable effect of soquelitinib treatment compared to placebo.
The soquelitinib mean EASI score reduction was 55.9% at 28 days (n=12) compared to mean EASI reduction of 27.0% in placebo. At day 58, continued improvement in the soquelitinib group was seen with mean EASI reduction of 69.1% (n=10) compared to mean EASI reduction of 19.1% for the placebo group.
<ul>
<li>At day 28, in the soquelitinib group, nine of 12 patients achieved EASI 50; three of 12 achieved EASI 75 and one of 12 achieved EASI 90. Three of the 12 patients achieved IGA 0 or 1. In the placebo group, two of four patients achieved EASI 50 and none achieved EASI 75, EASI 90, or IGA 0 or 1.</li>
<li>At day 58, in the soquelitinib group, nine of 10 patients achieved EASI 50, four of 10 achieved EASI 75 and one of 10 achieved EASI 90. Three of 10 patients achieved IGA 0 or 1. In the placebo group, one in four patients achieved EASI 50, and no patients achieved EASI 75, EASI 90, or IGA 0 or 1.</li>
</ul>
No significant safety issues were observed. All the patients completed 28 days of dosing. One patient reported Grade 1 nausea that did not interfere with the subject receiving the full treatment course, and one patient developed COVID-19 on day 28 of treatment; that patient had an uneventful recovery.
Price Action: CRVS stock is down 36.80% at $4.67 at the last check on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/24/12/42556198/united-microelectronics-signs-landmark-renewable-energy-deal-with-fengmiao-i-offshore-wind-farm-stock-gains" target="_blank" rel="noreferrer noopener">United Microelectronics Signs Landmark Renewable Energy Deal with Fengmiao I Offshore Wind Farm, Stock Gains</a></li>
</ul>

Health Care

CRVS

Why Is Corvus Pharmaceuticals Stock Trading Lower On Wednesday?

Toyota Motor shares are trading higher. The company announced it received funding from the US Department of Energy for the development of EV battery life cycles.

NVDA

NVIDIA shares are trading higher amid overall market strength ahead of the Fed's decision. Additionally, Omdia estimated that Microsoft bought 485,000 of Nvidia's Hopper chips this year.

PLTR

Palantir Technologies shares are trading higher after the company joined forces with Pray.com to enhance multilingual faith-based content using advanced AI technology.

Broadcom Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) shares are trading lower Wednesday, pulling back from a recent surge that saw the stock join the $1 trillion club. Here&#8217;s a look at what <a href="https://www.benzinga.com/24/12/42536512/market-breadth-worsens-as-tech-giants-break-free-from-sp-500-reality-is-this-bullish-or-bearish-for-2025">you need to know</a>.
What To Know: Broadcom shares have been on a tear over the past week, gaining nearly 40% since <a href="https://www.benzinga.com/news/earnings/24/12/42472970/broadcom-reports-mixed-q4-results-eps-beat-revenues-miss-q1-guidance-in-line-with-estimates">reporting earnings</a>. Broadcom shares soared after the company beat earnings estimates and provided strong guidance for AI-related revenue growth.
Broadcom&#8217;s fourth-quarter revenue was up 51% year-over-year to $14.05 billion, but came up short of estimates of $14.09 billion, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. Despite the miss on overall revenue, Broadcom reported a 220% increase in AI revenue and guided for significant growth in 2025. Positive commentary surrounding AI on the call also helped drive momentum to the upside.
Broadcom CEO Hock Tan said on the call with analysts and investors that he expects the total addressable market for the company&#8217;s AI chips to be between $60 billion and $90 billion over the next few years. He also announced that the company was working on custom AI chips with large cloud customers, <a href="https://www.cnbc.com/2024/12/13/broadcom-stock-jumps-21percent-pushing-company-past-1-trillion-market-cap-for-the-first-time.html">per</a> CNBC.
Reports from last week suggested that Broadcom was working with Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) on <a href="https://www.benzinga.com/trading-ideas/movers/24/12/42439155/broadcom-stock-jumps-on-apple-ai-chip-report-whats-going-on">AI chip development</a>. The company is reportedly working on development of an AI server chip&#8217;s networking technology. Broadcom shares got a boost from the news. 
Several analysts have weighed in with positive updates since the company reported fourth-quarter results. Multiple analysts maintained Overweight ratings, while others kept Buy ratings on the name. Newly-issued price targets range from $205 to $255. 
The weakness in Broadcom shares on Wednesday appears to be due to profit-taking in the wake of Broadcom&#8217;s incredible surge above the $1 trillion market cap mark. Broadcom shares hit new all-time highs this week, so the stock is likely to remain volatile as investors try to determine the appropriate value of the stock given the recent string of AI news.
It&#8217;s worth noting that Broadcom was among the top trending stocks on Reddit&#8217;s WallStreetBets on Wednesday, suggesting retail investors are also sizing up the name.
Check This Out: <a href="https://www.benzinga.com/24/12/42531167/broadcom-dethrones-nvidia-as-ais-new-darling-valuation-multiple-suggests-ai-momentum-shift">Broadcom Outpaces Nvidia In AI Chip Stock Valuation Race: Is Investor Sentiment Shifting?</a>
AVGO Price Action: <a href="http://benzinga.com/quote/avgo">Broadcom shares</a> were down 3.33% at $232.18 at the time of publication Wednesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

AAPL

AVGO

What's Going On With Broadcom Stock?

KULR Technology Group, Inc. (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KULR#AMEX">KULR</a>) shares are trading higher on Wednesday after the company announced it regained NYSE stockholder&#8217;s equity required compliance status. Here&#8217;s what you <a href="https://www.benzinga.com/24/12/42559178/worthington-enterprises-posts-upbeat-results-joins-jabil-archer-aviation-and-other-big-stocks-moving-higher-on-wednesday">need to know</a>.
What To Know: The company was previously cited for non-compliance with Sections 1003(a)(i), (ii) and (iii) of Part 10 of the NYSE American Company Guide in December 2023.
KULR has since demonstrated compliance with these standards for two consecutive quarters. Given the company&#8217;s compliance, the company has been removed from NYSE American noncompliant issuers on the exchange&#8217;s website.
How To Buy KULR Shares
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in KULR Tech Gr's case, it is in the Industrials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
Related Link: <a href="https://www.benzinga.com/24/12/42558554/abm-industries-earnings-beat-expectations-but-shares-slide-on-profit-decline">ABM Industries Stumbles Despite Q4 Earnings Beat &#8211; What&#8217;s Going On?</a>
KULR Price Action: At the time of writing, KULR shares are 76% higher at $2.57, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: Image via Shutterstock

KULR

What's Going On With KULR Technology Stock Wednesday?

Broadcom shares are trading lower, pulling back from its recent post-earnings surge.

LendingTree among financials gainers, Argo Blockchain in losers

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
The biggest pre-market stock movers are starting off the trading week as we check out all of the hottest news for Monday morning!



Moving stocks are clinical trial data, company merger plans, bankruptcy filings and more.



Let&rsquo;s get into that news down below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Yield10 Bioscience (NASDAQ:<a href="https://investorplace.com/stock-quotes/yten-stock-quote/">YTEN</a>) stock is rocketing more than 59% alongside heavy pre-market trading this morning.</li>



<li>Chenghe Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/chea-stock-quote/">CHEA</a>) shares are soaring over 37% following <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318029672&amp;type=PDF&amp;symbol=CHEA&amp;cdn=512bce218ae3f41dfa99fbb4fa603a82&amp;companyName=Chenghe+Acquisition+Co.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-02-02">shareholder approval for a merger plan</a>.</li>



<li>GRIID Infrastructure (NASDAQ:<a href="https://investorplace.com/stock-quotes/grdi-stock-quote/">GRDI</a>) stock is surging more than 34% with strong early morning trading.</li>



<li>4D Molecular Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/fdmt-stock-quote/">FDMT</a>) shares are soaring over 29% with <a href="https://www.marketwatch.com/story/4d-molecular-therapeutics-shares-rise-33-after-positive-trial-data-436613d6">positive clinical trial data</a>.</li>



<li>Tritium DCFC (NASDAQ:<a href="https://investorplace.com/stock-quotes/dcfc-stock-quote/">DCFC</a>) stock is gaining 28% after being the <a href="https://www.nasdaq.com/press-release/tritium-customers-win-largest-share-of-round-1-tennessee-nevi-program-2024-02-05">top-awarded fast-charger company</a> by Tennessee&rsquo;s National Electric Vehicle Infrastructure (NEVI) Formula Program.</li>



<li>Simplify Tail Risk Strategy (NYSEARCA:<a href="https://investorplace.com/stock-quotes/cya-stock-quote/">CYA</a>) shares are rising more than 17% on Monday morning.</li>



<li>Magic Empire Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/megl-stock-quote/">MEGL</a>) stock is climbing 15% as it sees heavy trading this morning.</li>



<li>BioRestorative Therapies (NASDAQ:<a href="https://investorplace.com/stock-quotes/brtx-stock-quote/">BRTX</a>) shares are jumping over 14% on Monday.</li>



<li>Alto Neuroscience (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANRO#NYSE">ANRO</a>) stock is getting a more than 14% boost following its <a href="https://www.marketwatch.com/story/alto-neuroscience-shares-soar-in-trading-debut-after-upsized-ipo-22f26d13">initial public offering</a>.</li>



<li>Catalent (NYSE:<a href="https://investorplace.com/stock-quotes/ctlt-stock-quote/">CTLT</a>) shares are up 13% after announcing a <a href="https://finance.yahoo.com/news/novo-holdings-buy-catalent-11-111946341.html">massive sale of the company</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Cano Health (NYSE:<a href="https://investorplace.com/stock-quotes/cano-stock-quote/">CANO</a>) stock is crashing more than 51% alongside <a href="https://www.nasdaq.com/press-release/cano-health-enters-restructuring-support-agreement-with-a-significant-majority-of-its">a bankruptcy filing</a>.</li>



<li>NanoString Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/nstg-stock-quote/">NSTG</a>) shares are plummeting over 49% after also <a href="https://www.nasdaq.com/press-release/nanostring-takes-steps-to-restructure-its-business-and-protect-its-mission-to-map-the">filing for bankruptcy protection</a>.</li>



<li>DMK Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/dmk-stock-quote/">DMK</a>) stock is diving more than 48% <a href="https://www.nasdaq.com/press-release/dmk-pharmaceuticals-commences-restructuring-proceeding-2024-02-02">following a bankruptcy filing</a>.</li>



<li>Bit Brother (NASDAQ:<a href="https://investorplace.com/stock-quotes/bets-stock-quote/">BETS</a>) shares are tumbling over 25% after getting <a href="https://www.nasdaq.com/press-release/bit-brother-limited-receives-notice-of-delisting-from-nasdaq-2024-02-02">a delisting notice</a>.</li>



<li>Jin Medical International (NASDAQ:<a href="https://investorplace.com/stock-quotes/zjyl-stock-quote/">ZJYL</a>) stock is dropping more than 18% without any clear news this morning.</li>



<li>Oragenics (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ogen-stock-quote/">OGEN</a>) shares are sliding over 13% on Monday morning.</li>



<li>Rail Vision (NASDAQ:<a href="https://investorplace.com/stock-quotes/rvsn-stock-quote/">RVSN</a>) stock is decreasing more than 12% ahead of <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318029931&amp;type=PDF&amp;symbol=RVSN&amp;cdn=4bbedcb1f3a7ff960c3216adeb5f2cde&amp;companyName=Rail+Vision+Ltd.&amp;formType=6-K%2FA&amp;formDescription=%5BAmend%5D+Report+of+foreign+issuer+%5BRules+13a-16+and+15d-16%5D&amp;dateFiled=2024-02-02">an extraordinary general shareholder meeting</a>.</li>



<li>Intelligent Bio Solutions (NASDAQ:<a href="https://investorplace.com/stock-quotes/inbs-stock-quote/">INBS</a>) shares are falling over 11% after <a href="https://www.globenewswire.com/news-release/2024/02/02/2822845/0/en/Intelligent-Bio-Solutions-Inc-Announces-Preliminary-Unaudited-Fiscal-Second-Quarter-and-Six-Month-Revenue-Results.html">releasing preliminary results for Q2</a>.</li>



<li>TruGolf (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUG#NASDAQ">TRUG</a>) stock is retreating more than 11% following its <a href="https://investorplace.com/2024/02/why-is-trugolf-trug-stock-up-35-today/">recent public debut</a>.</li>



<li>CCSC Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/cctg-stock-quote/">CCTG</a>) shares close out our pre-market stock movers down over 11% today.</li>
</ol>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/07/venture-capitalist-predicts-this-chatgpt-announcement-will-shock-the-world/?cid=MKT744191&amp;eid=MKT766413">ChatGPT IPO Could Shock the World, Make This Move Before the Announcement</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/02/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-feb-5th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!



Moving stocks are heavy trading, earnings reports, clinical trial news and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Next eGo (NASDAQ:<a href="https://investorplace.com/stock-quotes/egox-stock-quote/">EGOX</a>) stock is rocketing more than 110% alongside heavy pre-market trading this morning.</li>



<li>Intelligent Living Application (NASDAQ:<a href="https://investorplace.com/stock-quotes/ilag-stock-quote/">ILAG</a>) shares are soaring over 90% with strong early morning trading on Friday.</li>



<li>TC BioPharm (NASDAQ:<a href="https://investorplace.com/stock-quotes/tcbp-stock-quote/">TCBP</a>) stock is surging more than 75% with increased trading activity this morning.</li>



<li>Top Financial (NASDAQ:<a href="https://investorplace.com/stock-quotes/top-stock-quote/">TOP</a>) shares are gaining over 75% as it also experiences heavy trading on Friday.</li>



<li>Sunworks (NASDAQ:<a href="https://investorplace.com/stock-quotes/sunw-stock-quote/">SUNW</a>) stock is rising more than 38% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318035511&amp;type=PDF&amp;symbol=SUNW&amp;cdn=adc51c5aed5c71e14427762a8cf482ab&amp;companyName=Sunworks+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-02-06">despite a recent bankruptcy filing</a>.</li>



<li>Cheche (NASDAQ:<a href="https://investorplace.com/stock-quotes/ccg-stock-quote/">CCG</a>) shares are increasing over 30% without any clear news today.</li>



<li>Cloudflare (NYSE:<a href="https://investorplace.com/stock-quotes/net-stock-quote/">NET</a>) stock is climbing more than 27% <a href="https://www.cnbc.com/2024/02/08/cloudflare-net-q4-earnings-report-2023.html">alongside an earnings beat</a>.</li>



<li>Magic Empire Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/megl-stock-quote/">MEGL</a>) shares are jumping over 26% alongside strong early morning trading on Friday.</li>



<li>Central Garden &amp; Pet (NASDAQ:<a href="https://investorplace.com/stock-quotes/centa-stock-quote/">CENTA</a>) stock is getting a 25% boost <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318045374&amp;type=PDF&amp;symbol=CENT&amp;cdn=10c65ab88aa3d8ef8e519b4adb7f0d23&amp;companyName=Central+Garden+%26+Pet+Company&amp;formType=4&amp;formDescription=Statement+of+changes+in+beneficial+ownership+of+securities&amp;dateFiled=2024-02-08">on insider buying</a>.</li>



<li>Selina Hospitality (NASDAQ:<a href="https://investorplace.com/stock-quotes/slna-stock-quote/">SLNA</a>) shares are up more than 18% with strong trading this morning.</li>
</ol><h2>10 Top Losers</h2><ol></ol><ol><li>Synlogic (NASDAQ:<a href="https://investorplace.com/stock-quotes/sybx-stock-quote/">SYBX</a>) stock is plummeting 58% after <a href="https://finance.yahoo.com/news/synlogic-announces-decision-discontinue-synpheny-211500711.html">discontinuing a clinical trial</a>.</li>



<li>BioXcel Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/btai-stock-quote/">BTAI</a>) shares are diving over 40% after <a href="https://www.globenewswire.com/news-release/2024/02/08/2826423/0/en/BioXcel-Therapeutics-Announces-Proposed-Public-Offering.html">announcing a proposed public offering</a>.</li>



<li>Children&rsquo;s Place (NASDAQ:<a href="https://investorplace.com/stock-quotes/plce-stock-quote/">PLCE</a>) stock is tumbling more than 31% after releasing <a href="https://www.nasdaq.com/press-release/the-childrens-place-announces-preliminary-unaudited-results-for-the-fourth-quarter-0">preliminary earnings results</a>.</li>



<li>Renalytix (NASDAQ:<a href="https://investorplace.com/stock-quotes/rnlx-stock-quote/">RNLX</a>) shares are taking a close to 27% beating as it comes off a rally yesterday.</li>



<li>Syra Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/syra-stock-quote/">SYRA</a>) stock is dropping over 25% following a <a href="https://investorplace.com/2024/02/why-is-syra-health-syra-stock-up-285-today/">massive rally on Thursday</a>.</li>



<li>MicroCloud Hologram (NASDAQ:<a href="https://investorplace.com/stock-quotes/holo-stock-quote/">HOLO</a>) shares are retreating more than 25% after <a href="https://investorplace.com/2024/02/microcloud-hologram-holo-stock-pops-another-10-in-speculative-rally/">rallying the last two days</a>.</li>



<li>Hitek Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/hkit-stock-quote/">HKIT</a>) stock is sliding over 22% after a <a href="https://investorplace.com/2024/02/why-is-hitek-global-hkit-stock-up-518-today/">massive jump in price yesterday</a>.</li>



<li>Emcore (NASDAQ:<a href="https://investorplace.com/stock-quotes/emkr-stock-quote/">EMKR</a>) shares are falling more than 20% with its <a href="https://qz.com/emcore-fiscal-q1-earnings-snapshot-1851240456">latest earnings release</a>.</li>



<li>CCSC Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/cctg-stock-quote/">CCTG</a>) stock is slipping over 18% <a href="https://investorplace.com/2024/02/why-is-ccsc-technology-cctg-stock-up-107-today/">after a Thursday rally</a>.</li>



<li>MoneyHero (NASDAQ:<a href="https://investorplace.com/stock-quotes/mny-stock-quote/">MNY</a>) stock closes out our pre-market stock movers down more than 18% <a href="https://finance.yahoo.com/news/moneyhero-group-announces-resignation-chief-213000993.html">as its Chief Financial Officer resigns</a>.</li>
</ol>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/02/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-feb-9th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Magic Empire Global gets non-compliance notice from Nasdaq

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Shares of MicroAlgo (NASDAQ:<a href="https://investorplace.com/stock-quotes/mlgo-stock-quote/">MLGO</a>) stock are surging higher by over 650% after the company announced that it would establish a micro-consciousness quantum research center in collaboration with WiMi (NASDAQ:<a href="https://investorplace.com/stock-quotes/wimi-stock-quote/">WIMI</a>), its <a href="http://ir.microalgor.com/Upload/2024-04-12/6618a007c924d.pdf">parent company</a>. The research center will combine several disciplines, including physics, polymer chemistry and philosophy, in order to advance the study of consciousness.



&ldquo;The micro-consciousness quantum research center builds a bridge between basic science and applied technology, closely connecting the theoretical research of basic science and the practice of applied technology,&rdquo; said MicroAlgo.



The center&rsquo;s research will focus on four aspects: the Quantum computing and consciousness model, brain-computer interface technology, big data artificial intelligence (AI) and quantum consciousness and quantum-driven generative consciousness.



MicroAlgo and WiMi&rsquo;s research center will also collaborate with Chinese universities and research institutions on shared research, laboratory building and training.



MicroAlgo did not provide any further details, such as the costs to build such a center and any potential revenue impact. As a result, the move in MLGO is highly unusual and likely to reverse, echoing previous unusual moves in Chinese companies like AMTD Digital (NYSE:<a href="https://investorplace.com/stock-quotes/hkd-stock-quote/">HKD</a>) and Magic Empire Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/megl-stock-quote/">MEGL</a>). It&rsquo;s also worth noting that MLGO&rsquo;s float of <a href="https://finance.yahoo.com/quote/MLGO/key-statistics/">1.87 million shares</a> is extremely small, making the stock susceptible to sudden, volatile movements.



MicroAlgo&rsquo;s <a href="http://www.microalgor.com/">website</a> is also bare-bones and does not provide much information about the company.



<h2>5 Investors Betting Big on MLGO Stock in Q1</h2>



Tracking <a href="https://whalewisdom.com/stock/vena">institutional ownership</a> is important, as these large investors provide liquidity and support for stocks. However, MicroAlgo&rsquo;s institutional ownership is almost nonexistent, likely due to its status as a penny stock, falling sales and a lack of profitability.



As of the first quarter, only four 13F filers disclosed a stake in MLGO stock, a decline of nine filers compared to the prior quarter. These filers own a total of 10,862 shares, down by 77.52% from 48,313 shares during Q4. In addition, zero hedge funds reported a stake in the company.



The message from the Q1 13F data is quite clear: no one really cares or knows about MicroAlgo. With that in mind, let&rsquo;s take a look at its top shareholders as of Q1:



<ol><li>WiMi: 3.69 million shares. WiMi Q1 13D filing showed that it added 800,000 shares.</li>



<li>Chairman Jie Zhao: 1.85 million shares, accurate as of Dec. 31. These shares are owned by WiMi, while Zhao owns 100% of its Class A ordinary shares.</li>



<li>UBS Group (NYSE:<a href="https://investorplace.com/stock-quotes/ubs-stock-quote/">UBS</a>): 9,444 shares. UBS added 9,298 shares during Q1.</li>



<li>Tower Research Capital: 967 shares. Tower Research added 821 shares during Q1.</li>



<li>Morgan Stanley (NYSE:<a href="https://investorplace.com/stock-quotes/ms-stock-quote/">MS</a>): 450 shares. Morgan Stanley sold 204 shares during Q1.</li>
</ol>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.&nbsp;



Read More:&#8239;Penny Stocks &mdash; <a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>&nbsp;



On the date of publication, Eddie Pan did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines</a>.&nbsp;
<div>Eddie Pan specializes in institutional investments and insider activity. He writes for InvestorPlace&rsquo;s Today&rsquo;s Market team, which centers on the latest news involving popular stocks.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/5-investors-betting-on-microalgo-mlgo-stock-in-q1/">5 Investors Betting on MicroAlgo (MLGO) Stock in Q1</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

5 Investors Betting on MicroAlgo (MLGO) Stock in Q1

Magic Empire Global Ltd. (MEGL) has released an update. Magic Empire Global Limited has received an additional 180 days from Nasdaq to meet the min...

Magic Empire Global Granted Nasdaq Compliance Extension

Magic Empire Global Ltd. (MEGL) has released an update. Magic Empire Global Ltd. reported a significant 26.9% increase in revenue for the first hal...

Magic Empire Global Ltd. Sees Revenue Surge Amid Rising Costs

Magic Empire Global Limited reports 1H results

Magic Empire Global Ltd. (MEGL) has released an update. Magic Empire Global Ltd. has scheduled its annual shareholder meeting for November 29, 2024...

Magic Empire Global Ltd. Announces Key Shareholder Meeting

Magic Empire Global Ltd. (MEGL) has released an update. Magic Empire Global Ltd. successfully held its 2024 annual general meeting where key resolu...

Magic Empire Global Ltd. Restructures Share Classes and Leadership

ANRO

ARBK

BRTX

BTAI

CENTA

EGOX

EMKR

HKIT

HOLO

ILAG

INBS

MIGI

MLGO

OGEN

PLCE

RNLX

RVSN

SEZL

SLNA

SUNW

SYBX

SYRA

TCBP

TCJH

TREE

TRUG

WIMI

YTEN

ZJYL

Press Releases

Magic Empire Global Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Magic Empire Global Limited Announces Receipt of Nasdaq Notification of additional 180 calendar day period to regain compliance of minimum bid price requirement

Magic Empire Global Limited Announces First Half 2024 Unaudited Financial Results

AMTD IDEA Group American Depositary Shares, each representing six (6) Class A Ordinary Shares

Comments

Magic Empire Glb

Magic Empire Glb (MEGL) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga